Cargando…
A human β-III-spectrin spinocerebellar ataxia type 5 mutation causes high-affinity F-actin binding
Spinocerebellar ataxia type 5 (SCA5) is a human neurodegenerative disease that stems from mutations in the SPTBN2 gene encoding the protein β-III-spectrin. Here we investigated the molecular consequence of a SCA5 missense mutation that results in a L253P substitution in the actin-binding domain (ABD...
Autores principales: | Avery, Adam W., Crain, Jonathan, Thomas, David D., Hays, Thomas S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756369/ https://www.ncbi.nlm.nih.gov/pubmed/26883385 http://dx.doi.org/10.1038/srep21375 |
Ejemplares similares
-
Increased actin binding is a shared molecular consequence of numerous spinocerebellar ataxia mutations in β-III-spectrin
por: Atang, Alexandra E., et al.
Publicado: (2023) -
Early-phase drug discovery of β-III-spectrin actin-binding modulators for treatment of spinocerebellar ataxia type 5
por: Guhathakurta, Piyali, et al.
Publicado: (2023) -
Novel drug discovery platform for spinocerebellar ataxia, using fluorescence technology targeting β-III-spectrin
por: Rebbeck, Robyn T., et al.
Publicado: (2020) -
β-III-spectrin N-terminus is required for high-affinity actin binding and SCA5 neurotoxicity
por: Denha, Sarah A., et al.
Publicado: (2022) -
Structural basis for high-affinity actin binding revealed by a β-III-spectrin SCA5 missense mutation
por: Avery, Adam W., et al.
Publicado: (2017)